Search research articles
Contact Us
Filters
Showing results (31-40 of 48) with videos related to
Page
of 5
Sort By:
The Journal of Biological Chemistry
|
February 24, 2018
Impact of the epoxide hydrolase EphD on the metabolism of mycolic acids in mycobacteria
Jan Madacki, Françoise Laval, Anna Grzegorzewicz, et al.
Cancer Immunity
|
May 16, 2003
Urine antibody against human cancer antigen NY-ESO-1
Dirk Jäger, Elisabeth Stockert, Julia Karbach, et al.
Cancer Immunity
|
May 16, 2003
Identification of a naturally processed NY-ESO-1 peptide recognized by CD8+ T cells in the context of HLA-B51
Elke Jäger, Julia Karbach, Sacha Gnjatic, et al.
Biochimica Et Biophysica Acta
|
August 19, 2003
Biochemical characterization of Aspergillus awamori exoinulinase: substrate binding characteristics and regioselectivity of hydrolysis
Anna A Kulminskaya, Michael Arand, Elena V Eneyskaya, et al.
Journal of the American Chemical Society
|
May 28, 2009
Directed evolution of an enantioselective epoxide hydrolase: uncovering the source of enantioselectivity at each evolutionary stage
Manfred T Reetz, Marco Bocola, Li-Wen Wang, et al.
Organic Letters
|
January 16, 2004
Enhancing the enantioselectivity of an epoxide hydrolase by directed evolution
Manfred T Reetz, Claudia Torre, Andreas Eipper, et al.
The EMBO Journal
|
May 30, 2003
Structure of Rhodococcus erythropolis limonene-1,2-epoxide hydrolase reveals a novel active site
Michael Arand, B Martin Hallberg, Jinyu Zou, et al.
Cancer Immunity
|
December 17, 2004
HLA-DP4 expression and immunity to NY-ESO-1: correlation and characterization of cytotoxic CD4+ CD25- CD8- T cell clones
Eduardo Huarte, Julia Karbach, Sacha Gnjatic, et al.
Journal of Lipid Research
|
July 17, 2012
EH3 (ABHD9): the first member of a new epoxide hydrolase family with high activity for fatty acid epoxides
Martina Decker, Magdalena Adamska, Annette Cronin, et al.
Archives of Toxicology
|
July 18, 2024
Identification of reversible OATP1B1 and time-dependent CYP3A4 inhibition as the major risk factors for drug-induced cholestasis (DIC)
Vlasia Kastrinou-Lampou, Raquel Rodríguez-Pérez, Birk Poller, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 48) with videos related to
Sort By:
Page
of 5
The Journal of Biological Chemistry
|
February 24, 2018
Impact of the epoxide hydrolase EphD on the metabolism of mycolic acids in mycobacteria
Jan Madacki, Françoise Laval, Anna Grzegorzewicz, et al.
Cancer Immunity
|
May 16, 2003
Urine antibody against human cancer antigen NY-ESO-1
Dirk Jäger, Elisabeth Stockert, Julia Karbach, et al.
Cancer Immunity
|
May 16, 2003
Identification of a naturally processed NY-ESO-1 peptide recognized by CD8+ T cells in the context of HLA-B51
Elke Jäger, Julia Karbach, Sacha Gnjatic, et al.
Biochimica Et Biophysica Acta
|
August 19, 2003
Biochemical characterization of Aspergillus awamori exoinulinase: substrate binding characteristics and regioselectivity of hydrolysis
Anna A Kulminskaya, Michael Arand, Elena V Eneyskaya, et al.
Journal of the American Chemical Society
|
May 28, 2009
Directed evolution of an enantioselective epoxide hydrolase: uncovering the source of enantioselectivity at each evolutionary stage
Manfred T Reetz, Marco Bocola, Li-Wen Wang, et al.
Organic Letters
|
January 16, 2004
Enhancing the enantioselectivity of an epoxide hydrolase by directed evolution
Manfred T Reetz, Claudia Torre, Andreas Eipper, et al.
The EMBO Journal
|
May 30, 2003
Structure of Rhodococcus erythropolis limonene-1,2-epoxide hydrolase reveals a novel active site
Michael Arand, B Martin Hallberg, Jinyu Zou, et al.
Cancer Immunity
|
December 17, 2004
HLA-DP4 expression and immunity to NY-ESO-1: correlation and characterization of cytotoxic CD4+ CD25- CD8- T cell clones
Eduardo Huarte, Julia Karbach, Sacha Gnjatic, et al.
Journal of Lipid Research
|
July 17, 2012
EH3 (ABHD9): the first member of a new epoxide hydrolase family with high activity for fatty acid epoxides
Martina Decker, Magdalena Adamska, Annette Cronin, et al.
Archives of Toxicology
|
July 18, 2024
Identification of reversible OATP1B1 and time-dependent CYP3A4 inhibition as the major risk factors for drug-induced cholestasis (DIC)
Vlasia Kastrinou-Lampou, Raquel Rodríguez-Pérez, Birk Poller, et al.
Page
of 5